STOCK TITAN

Burke & Herbert Financial (BHRB) EVP exercises 17,120 rights, 12,914 withheld

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Burke & Herbert Financial Services Corp. executive vice president Robert S. Tissue exercised a total of 17,120 stock-settled appreciation rights into common stock on July 30, 2026.

The exercises produced common shares at $43.33 and $52.29 per share, with 12,914 shares at $73.63 withheld to satisfy exercise-price or tax obligations. An additional 373 shares are reported as held indirectly by his spouse.

Positive

  • None.

Negative

  • None.
Insider TISSUE ROBERT S
Role EVP, Balance Sheet Strategy
Type Security Shares Price Value
Exercise Stock Settled Appreciation Rights 8,684 $0.00 $0.00
Exercise Stock Settled Appreciation Rights 8,436 $0.00 $0.00
Exercise Common Stock 8,684 $43.33 $376K
Exercise Common Stock 8,436 $52.29 $441K
Exercise Price or Tax Liability Common Stock 12,914 $73.63 $951K
holding Common Stock -- -- --
Holdings After Transaction: Stock Settled Appreciation Rights — 0 shares (Direct); Common Stock — 58,064 shares (Direct); Common Stock — 373 shares (Indirect, By Spouse)
Stock rights exercised 17,120 shares Aggregate common shares from derivative exercises on July 30, 2026
Exercise price (first grant) $43.33 per share 8,684 stock-settled appreciation rights exercised into common stock on July 30, 2026
Exercise price (second grant) $52.29 per share 8,436 stock-settled appreciation rights exercised into common stock on July 30, 2026
Shares withheld for tax or exercise 12,914 shares at $73.63 per share Common stock disposed of under code F on July 30, 2026
Indirect spouse holdings 373 shares Common stock held indirectly by spouse after the reported transactions
Stock Settled Appreciation Rights financial
"security_title: Stock Settled Appreciation Rights, exercised into common stock"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise-price-or-tax-liability disposition financial
"transaction_action: exercise-price-or-tax-liability disposition of common stock"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did BHRB executive Robert S. Tissue report in this Form 4?

Robert S. Tissue, an EVP at BHRB, reported exercising 17,120 stock-settled appreciation rights into common stock on July 30, 2026, with a portion of the resulting shares withheld to cover exercise-price or tax obligations.

How many stock-settled appreciation rights did BHRB EVP Tissue exercise?

He exercised a total of 17,120 stock-settled appreciation rights, consisting of 8,684 rights at an exercise price of $43.33 per share and 8,436 rights at an exercise price of $52.29 per share.

How many BHRB shares were withheld for tax or exercise obligations?

The filing reports that 12,914 shares of common stock, valued at $73.63 per share, were disposed of under code F, meaning they were withheld to satisfy exercise-price or tax-liability obligations related to the equity awards.

Were the BHRB transactions made under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox is marked false, indicating the transactions are not affirmed as having been executed pursuant to a Rule 10b5-1 trading plan, based on the disclosure provided.

What indirect BHRB shareholdings are reported for Tissue and his family?

The Form 4 shows an indirect holding of 373 shares of BHRB common stock listed as owned "By Spouse," indicating these shares are attributed to his spouse rather than as a direct personal holding.

What types of securities are involved in this BHRB Form 4 filing?

The transactions involve Stock Settled Appreciation Rights, which are derivative securities, being exercised into common stock, followed by an F-code disposition where some common shares were withheld for exercise-price or tax-liability purposes.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TISSUE ROBERT S

(Last)(First)(Middle)
100 SOUTH FAIRFAX STREET

(Street)
ALEXANDRIA VIRGINIA 22314

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Burke & Herbert Financial Services Corp. [ BHRB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Balance Sheet Strategy
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/30/2026M8,684A$43.3362,542D
Common Stock07/30/2026M8,436A$52.2970,978D
Common Stock07/30/2026F12,914D$73.6358,064D
Common Stock373IBy Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Settled Appreciation Rights$43.3307/30/2026M8,68407/15/202107/15/2031Common Stock8,684$00D
Stock Settled Appreciation Rights$52.2907/30/2026M8,43602/09/202302/09/2033Common Stock8,436$00D
Explanation of Responses:
Remarks:
/s/ Matthew Rucker, as Attorney-in-Fact for Robert S. Tissue08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)